[ad_1]
Bulgaria is the only country that has given up on Jansen, but the government has decided to take steps to ensure the supply of the vaccine. This was shared by the Minister of Health Kostadin Angelov.Kostadin Angelov was born on June 7, 1977. He graduated from Sofia Medical University in 2004. during the Health Committee meeting regarding vaccines.
All on the topic:
Coronavirus epidemic (COVID-19) 16109
After the expiration of the deadline for the explicit refusal to participate with the drug manufacturer of the pharmaceutical company “Jansen” in the EC information was received that only Bulgaria has surrendered. Given the described pan-European vision of guaranteeing equal access to vaccines for EU citizens, at its meeting the government approved a protocol decision to take measures on our part to guarantee the supply of the vaccine offered by the pharmaceutical company ” Jansen “. The legal mechanism for receiving doses of this vaccine will be implemented through an agreement with another Member State, which will declare and provide Bulgaria with the requested quantities of the vaccine at the same price, ”Angelov added.
He clarified that the agreements provide that the participating countries donate and resell quantities of vaccines to other countries and public institutions with the consent of the contractor.
If a resale is made to any third country, the participating country reselling the dose has an obligation to reimburse the commission for the advance on the dose, Angelov added.
Currently, Bulgaria has entered into contracts with the companies AstraZeneca and Sanofi for a vaccine against COVID-19.
The members of the commission adopted a draft decision approving the participation of the Republic of Bulgaria in the preliminary agreements concluded by the European Commission and the drug manufacturers “AstraZeneca”, “Sanofi” and “Pfizer Inc” and “BioNTech Manufacturing” GmbH and for the purchase of vaccines in connection with the COVID-19 pandemic, as well as taking steps to enter into a vaccine purchase contract from Janssen Pharmaceutica NV in principle.
All on the topic:
Coronavirus epidemic (COVID-19)
16109
More about the coronavirus
[ad_2]